Arcturus Therapeutics Holdings Inc.

Schonfeld Strategic Advisors LLC ARCT

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

69,755

Value ($000)

428

Weight

0.0%

2020 Q2 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	428	0.0%	69,755	12/31/2025
2025 Q3	11/14/2025	12,308	0.1%	667,827	9/30/2025
2025 Q1	5/15/2025	8,745	0.1%	825,766	3/31/2025
2024 Q4	2/14/2025	14,409	0.1%	849,081	12/31/2024
2024 Q3	11/14/2024	8,578	0.1%	369,599	9/30/2024
2024 Q2	8/14/2024	6,901	0.1%	283,420	6/30/2024
2024 Q1	5/15/2024	11,701	0.1%	346,494	3/31/2024
2023 Q4	2/14/2024	12,659	0.1%	401,481	12/31/2023
2023 Q3	11/14/2023	2,738	0.0%	107,156	9/30/2023
2022 Q3	11/14/2022	616	0.0%	41,567	9/30/2022
2022 Q2	8/15/2022	4,212	0.0%	267,597	6/30/2022
2022 Q1	5/16/2022	2,052	0.0%	76,096	3/31/2022
2021 Q4	2/14/2022	2,063	0.0%	55,748	12/31/2021
2021 Q3	11/16/2021	4,808	0.1%	100,627	9/30/2021
2021 Q2	11/16/2021	796	0.0%	23,532	6/30/2021
2021 Q1	5/17/2021	793	0.0%	19,208	3/31/2021
2020 Q4	2/16/2021	1,530	0.0%	35,268	12/31/2020
2020 Q3	11/19/2020	7,051	0.1%	164,370	9/30/2020
2020 Q2	8/14/2020	908	0.0%	19,437	6/30/2020